Nadir Yehya1, Carol L Hodgson2,3, Marcelo B P Amato4, Jean-Christophe Richard5,6, Laurent J Brochard7,8, Alain Mercat5, Ewan C Goligher7,9,10. 1. Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania. 2. Intensive Care Unit, Alfred Hospital, Melbourne, Victoria, Australia. 3. Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. 4. Laboratório de Pneumologia LIM-09, Disciplina de Pneumologia, Heart Institute (Incor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil. 5. Département de Réanimation Médicale et Médecine Hyperbare, Centre Hospitalier Universitaire (CHU) d'Angers, Angers, France. 6. Institut National de la Santé et Recherche Médicale, Creteil, France. 7. Interdepartmental Division of Critical Care, University of Toronto, Toronto, Ontario, Canada. 8. Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada. 9. Division of Respirology, Department of Medicine, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; and. 10. Toronto General Hospital Research Institute, Toronto, Ontario, Canada.
Abstract
Rationale: Clinicians commonly use short-term physiologic markers to assess the benefit of ventilator adjustments. Improved arterial oxygen tension/pressure (PaO2)/fraction of inspired oxygen (FiO2) after ventilator adjustment in acute respiratory distress syndrome is associated with lower mortality. However, as driving pressure (ΔP) reflects lung stress and strain, changes in ΔP may more accurately reflect benefits or harms of ventilator adjustments compared with changes in oxygenation. Objectives: We aimed to compare the association between mortality and the changes in PaO2/FiO2 and ΔP following protocolized ventilator changes. Methods: We assessed associations between mortality and changes in PaO2/FiO2 (ΔPaO2/FiO2) and ΔP (ΔΔP) after postrandomization positive end-expiratory pressure (PEEP) and tidal volume adjustment in reanalyses of the ALVEOLI (Assessment of Low Tidal Volume and Elevated End-Expiratory Volume to Obviate Lung Injury) and ExPress (Expiratory Pressure) trials. We included subjects with available pre- and postintervention PaO2/FiO2 and ΔP (372 in ALVEOLI and 596 in ExPress). In each separate trial cohort, we performed multivariable Cox regression testing the association between ΔPaO2/FiO2 and ΔΔP with mortality. Results: In ALVEOLI, when analyzed as separate variables, ΔPaO2/FiO2 was associated with mortality only in subjects in whom PEEP increased, whereas ΔΔP was associated with mortality irrespective of direction of PEEP change. When modeled together, improved ΔPaO2/FiO2 was not associated with mortality, whereas ΔΔP remained associated with mortality (adjusted hazard ratio [aHR], 1.50 per 5 cm H2O increase; 95% confidence interval [95% CI], 1.21-1.85). When modeled together in ExPress, ΔΔP (aHR, 1.42; 95% CI, 1.14-1.78) was more strongly associated with mortality than ΔPaO2/FiO2 (aHR, 0.95 per 25 mm Hg increase; 95% CI, 0.90-1.00).Conclusions: Reduced ΔP following protocolized ventilator changes was more strongly and consistently associated with lower mortality than was increased PaO2/FiO2, making ΔΔP more informative about benefit from ventilator adjustments. Our results reinforce the primacy of ΔP, rather than oxygenation, as the key variable associated with outcome.
Rationale: Clinicians commonly use short-term physiologic markers to assess the benefit of ventilator adjustments. Improved arterial oxygen tension/pressure (PaO2)/fraction of inspired oxygen (FiO2) after ventilator adjustment in acute respiratory distress syndrome is associated with lower mortality. However, as driving pressure (ΔP) reflects lung stress and strain, changes in ΔP may more accurately reflect benefits or harms of ventilator adjustments compared with changes in oxygenation. Objectives: We aimed to compare the association between mortality and the changes in PaO2/FiO2 and ΔP following protocolized ventilator changes. Methods: We assessed associations between mortality and changes in PaO2/FiO2 (ΔPaO2/FiO2) and ΔP (ΔΔP) after postrandomization positive end-expiratory pressure (PEEP) and tidal volume adjustment in reanalyses of the ALVEOLI (Assessment of Low Tidal Volume and Elevated End-Expiratory Volume to Obviate Lung Injury) and ExPress (Expiratory Pressure) trials. We included subjects with available pre- and postintervention PaO2/FiO2 and ΔP (372 in ALVEOLI and 596 in ExPress). In each separate trial cohort, we performed multivariable Cox regression testing the association between ΔPaO2/FiO2 and ΔΔP with mortality. Results: In ALVEOLI, when analyzed as separate variables, ΔPaO2/FiO2 was associated with mortality only in subjects in whom PEEP increased, whereas ΔΔP was associated with mortality irrespective of direction of PEEP change. When modeled together, improved ΔPaO2/FiO2 was not associated with mortality, whereas ΔΔP remained associated with mortality (adjusted hazard ratio [aHR], 1.50 per 5 cm H2O increase; 95% confidence interval [95% CI], 1.21-1.85). When modeled together in ExPress, ΔΔP (aHR, 1.42; 95% CI, 1.14-1.78) was more strongly associated with mortality than ΔPaO2/FiO2 (aHR, 0.95 per 25 mm Hg increase; 95% CI, 0.90-1.00).Conclusions: Reduced ΔP following protocolized ventilator changes was more strongly and consistently associated with lower mortality than was increased PaO2/FiO2, making ΔΔP more informative about benefit from ventilator adjustments. Our results reinforce the primacy of ΔP, rather than oxygenation, as the key variable associated with outcome.
Authors: Marc Moss; David T Huang; Roy G Brower; Niall D Ferguson; Adit A Ginde; M N Gong; Colin K Grissom; Stephanie Gundel; Douglas Hayden; R Duncan Hite; Peter C Hou; Catherine L Hough; Theodore J Iwashyna; Akram Khan; Kathleen D Liu; Daniel Talmor; B Taylor Thompson; Christine A Ulysse; Donald M Yealy; Derek C Angus Journal: N Engl J Med Date: 2019-05-19 Impact factor: 91.245
Authors: Ewan C Goligher; Brian P Kavanagh; Gordon D Rubenfeld; Niall D Ferguson Journal: Am J Respir Crit Care Med Date: 2015-12-15 Impact factor: 21.405
Authors: Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler Journal: N Engl J Med Date: 2000-05-04 Impact factor: 91.245
Authors: Matthias Briel; Maureen Meade; Alain Mercat; Roy G Brower; Daniel Talmor; Stephen D Walter; Arthur S Slutsky; Eleanor Pullenayegum; Qi Zhou; Deborah Cook; Laurent Brochard; Jean-Christophe M Richard; Francois Lamontagne; Neera Bhatnagar; Thomas E Stewart; Gordon Guyatt Journal: JAMA Date: 2010-03-03 Impact factor: 56.272
Authors: Maureen O Meade; Deborah J Cook; Gordon H Guyatt; Arthur S Slutsky; Yaseen M Arabi; D James Cooper; Andrew R Davies; Lori E Hand; Qi Zhou; Lehana Thabane; Peggy Austin; Stephen Lapinsky; Alan Baxter; James Russell; Yoanna Skrobik; Juan J Ronco; Thomas E Stewart Journal: JAMA Date: 2008-02-13 Impact factor: 56.272
Authors: Ewan C Goligher; Brian P Kavanagh; Gordon D Rubenfeld; Neill K J Adhikari; Ruxandra Pinto; Eddy Fan; Laurent J Brochard; John T Granton; Alain Mercat; Jean-Christophe Marie Richard; Jean-Marie Chretien; Graham L Jones; Deborah J Cook; Thomas E Stewart; Arthur S Slutsky; Maureen O Meade; Niall D Ferguson Journal: Am J Respir Crit Care Med Date: 2014-07-01 Impact factor: 21.405
Authors: Renata R Rodrigues; Aline M Ambrósio; Aline M Engbruch; Lucas A Gonçalves; Paula A Villela; Ana F Sanchez; Denise T Fantoni Journal: Front Vet Sci Date: 2022-03-15
Authors: Gary Nieman; Michaela Kollisch-Singule; Harry Ramcharran; Joshua Satalin; Sarah Blair; Louis A Gatto; Penny Andrews; Auyon Ghosh; David W Kaczka; Donald Gaver; Jason Bates; Nader M Habashi Journal: Crit Care Date: 2022-08-07 Impact factor: 19.334